| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Frequent inactivation of PTEN in prostate cancer cell lines and xenografts.
|
Cancer Res
|
1998
|
2.10
|
|
2
|
In vivo and in vitro complex formation of prostate specific antigen with alpha 1-anti-chymotrypsin.
|
Prostate
|
1995
|
2.07
|
|
3
|
Characterization of a zinc-finger protein and its association with apoptosis in prostate cancer cells.
|
J Natl Cancer Inst
|
2000
|
1.78
|
|
4
|
Adrenal glands of mouse and rat do not synthesize androgens.
|
Life Sci
|
1992
|
1.64
|
|
5
|
Development of seven new human prostate tumor xenograft models and their histopathological characterization.
|
Am J Pathol
|
1996
|
1.29
|
|
6
|
Chemosensitivity of prostate cancer cell lines and expression of multidrug resistance-related proteins.
|
Eur J Cancer
|
1999
|
1.16
|
|
7
|
Differentially expressed genes in androgen-dependent and -independent prostate carcinomas.
|
Cancer Res
|
1997
|
1.11
|
|
8
|
Effect of culture conditions on androgen sensitivity of the human prostatic cancer cell line LNCaP.
|
Prostate
|
1993
|
1.05
|
|
9
|
EGR-1 enhances tumor growth and modulates the effect of the Wilms' tumor 1 gene products on tumorigenicity.
|
Oncogene
|
2000
|
0.99
|
|
10
|
Expression and prognostic value of epidermal growth factor receptor, transforming growth factor-alpha, and c-erb B-2 in nephroblastoma.
|
Cancer
|
2001
|
0.98
|
|
11
|
Effects of low testosterone levels and of adrenal androgens on growth of prostate tumor models in nude mice.
|
J Steroid Biochem Mol Biol
|
1990
|
0.98
|
|
12
|
Castration-induced changes in morphology, androgen levels, and proliferative activity of human prostate cancer tissue grown in athymic nude mice.
|
Prostate
|
1993
|
0.97
|
|
13
|
The prognostic value of CD44 isoforms in prostate cancer patients treated by radical prostatectomy.
|
Clin Cancer Res
|
1997
|
0.94
|
|
14
|
Androgen deprivation of the PC-310 [correction of prohormone convertase-310] human prostate cancer model system induces neuroendocrine differentiation.
|
Cancer Res
|
2000
|
0.94
|
|
15
|
Neuroendocrine differentiation in human prostatic tumor models.
|
Am J Pathol
|
1996
|
0.92
|
|
16
|
Expression and prognostic relevance of vascular endothelial growth factor (VEGF) and its receptor (FLT-1) in nephroblastoma.
|
J Clin Pathol
|
2003
|
0.92
|
|
17
|
Neutrons and X-rays, comparative studies with Drosophila melanogaster. 1. The viability and fertility of induced autosomal translocations.
|
Mutat Res
|
1981
|
0.91
|
|
18
|
Regulation of expression of Na+,K+-ATPase in androgen-dependent and androgen-independent prostate cancer.
|
Br J Cancer
|
1999
|
0.90
|
|
19
|
Alloimmunization against the MHC antigens after platelet transfusions is due to contaminating leukocytes in the platelet suspension.
|
Exp Hematol
|
1981
|
0.90
|
|
20
|
Decreased levels of topoisomerase II alpha in human renal cell carcinoma lines resistant to etoposide.
|
J Cancer Res Clin Oncol
|
1997
|
0.89
|
|
21
|
The use of steroid-containing Silastic implants in male nude mice: plasma hormone levels and the effect of implantation on the weights of the ventral prostate and seminal vesicles.
|
Prostate
|
1984
|
0.88
|
|
22
|
Neuroendocrine cells in the normal, hyperplastic and neoplastic prostate.
|
Urol Res
|
1995
|
0.87
|
|
23
|
Androgen-independent growth is induced by neuropeptides in human prostate cancer cell lines.
|
Prostate
|
2000
|
0.87
|
|
24
|
Determination of the proliferative fraction of a transplantable, hormone-dependent, human prostatic carcinoma (PC-82) by monoclonal antibody Ki-67: potential application for hormone therapy monitoring.
|
J Natl Cancer Inst
|
1987
|
0.87
|
|
25
|
Expression of cellular oncogenes in human prostatic carcinoma cell lines.
|
Biochem Biophys Res Commun
|
1985
|
0.87
|
|
26
|
The prognostic significance of apoptosis-associated proteins BCL-2, BAX and BCL-X in clinical nephroblastoma.
|
Br J Cancer
|
2001
|
0.86
|
|
27
|
The prognostic influence of neuroendocrine cells in prostate cancer: results of a long-term follow-up study with patients treated by radical prostatectomy.
|
Int J Cancer
|
1995
|
0.86
|
|
28
|
Silencing of CD44 expression in prostate cancer by hypermethylation of the CD44 promoter region.
|
Lab Invest
|
2000
|
0.86
|
|
29
|
Kinetics of neuroendocrine differentiation in an androgen-dependent human prostate xenograft model.
|
Am J Pathol
|
1999
|
0.86
|
|
30
|
Identification of a gene on human chromosome 8q11 that is differentially expressed during prostate-cancer progression.
|
Int J Cancer
|
1999
|
0.86
|
|
31
|
Decreased expression of CD44 in metastatic prostate cancer.
|
Int J Cancer
|
1999
|
0.86
|
|
32
|
Assessment of the critical level of androgen for growth response of transplantable human prostatic carcinoma (PC-82) in nude mice.
|
J Urol
|
1991
|
0.86
|
|
33
|
Serum free prostate specific antigen: isoenzymes in benign hyperplasia and cancer of the prostate.
|
Prostate
|
1995
|
0.84
|
|
34
|
Application of the monoclonal antibody Ki-67 on prostate biopsies to assess the fraction of human prostatic carcinoma.
|
J Urol
|
1991
|
0.84
|
|
35
|
Immunohistochemical evaluation of the expression of prostate tumor-association markers in the nude mouse human prostate carcinoma heterotransplant lines PC-82, PC-EW, and PC-EG.
|
Prostate
|
1990
|
0.82
|
|
36
|
Variations in activin receptor, inhibin/activin subunit and follistatin mRNAs in human prostate tumour tissues.
|
Br J Cancer
|
2000
|
0.81
|
|
37
|
Biological effects of hormonal treatment regimens on a transplantable human prostatic tumor line (PC-82).
|
J Urol
|
1984
|
0.81
|
|
38
|
Effects of adrenal androgens on the transplantable human prostate tumor PC-82.
|
Endocrinology
|
1992
|
0.81
|
|
39
|
The prognostic value of pretreatment expression of androgen receptor and bcl-2 in hormonally treated prostate cancer patients.
|
J Urol
|
1997
|
0.81
|
|
40
|
Administration of an LHRH-antagonist to male mice: effects on in vivo secretion of hormones and on the growth of a transplantable human prostatic carcinoma.
|
Life Sci
|
1987
|
0.80
|
|
41
|
Progress of fundamental research in Wilms' tumor.
|
Urol Res
|
1997
|
0.79
|
|
42
|
Recent advances in the development of animal and cell culture models for prostate cancer research A minireview.
|
Urol Oncol
|
2011
|
0.79
|
|
43
|
Ki-67 expression and BrdUrd incorporation as markers of proliferative activity in human prostate tumour models.
|
Cell Prolif
|
1993
|
0.78
|
|
44
|
Human prostate cancer (PC-82) in nude mice: a model to study androgen regulated tumor growth.
|
Prog Clin Biol Res
|
1985
|
0.78
|
|
45
|
Regulation of androgen receptor expression in the human heterotransplantable prostate carcinoma PC-82.
|
Endocrinology
|
1992
|
0.77
|
|
46
|
Characterization of androgen receptors after photoaffinity labelling with [3H]methyltrienolone (R1881).
|
J Steroid Biochem
|
1986
|
0.77
|
|
47
|
Differential sensitivity of hormone-responsive and unresponsive human prostate cancer cells (LNCaP) to tumor necrosis factor.
|
Urol Res
|
1992
|
0.77
|
|
48
|
Characterization of chromosome 8 aberrations in the prostate cancer cell line LNCaP-FGC and sublines.
|
Urol Res
|
1999
|
0.77
|
|
49
|
Characterization of androgen receptors in a transplantable human prostatic adenocarcinoma (PC-82).
|
Prostate
|
1987
|
0.77
|
|
50
|
Expression of HLA-like structures on a permanent human tumor line PC-93.
|
Tissue Antigens
|
1983
|
0.76
|
|
51
|
The cytocidal effect of high energy shock waves on human prostatic tumour cell lines.
|
Eur J Cancer Clin Oncol
|
1989
|
0.76
|
|
52
|
Determination of Ki-67 defined growth fraction by monoclonal antibody MIB-1 in formalin-fixed, paraffin-embedded prostatic cancer tissues.
|
Prostate
|
1995
|
0.76
|
|
53
|
Hormone receptors in human prostate cancer.
|
Scand J Urol Nephrol Suppl
|
1988
|
0.75
|
|
54
|
Nuclear protein as a prognostic factor of growth activity in prostatic adenocarcinoma.
|
Urol Res
|
1996
|
0.75
|
|
55
|
A novel gene on human chromosome 2p24 is differentially expressed between androgen-dependent and androgen-independent prostate cancer cells.
|
Eur J Cancer
|
2001
|
0.75
|
|
56
|
Pharmacia Award 1990. The biological significance of low testosterone levels and of adrenal androgens in transplantable prostate cancer lines.
|
Urol Res
|
1991
|
0.75
|
|
57
|
In vivo administration of a GnRH antagonist to male mice: effects on pituitary gonadotropin secretion in vitro.
|
Acta Endocrinol (Copenh)
|
1989
|
0.75
|
|
58
|
Inhibition of apoptotic proteins causes multidrug resistance in renal carcinoma cells.
|
Anticancer Res
|
2002
|
0.75
|
|
59
|
Peptidylglycine alpha-amidating monooxygenase- and proadrenomedullin-derived peptide-associated neuroendocrine differentiation are induced by androgen deprivation in the neoplastic prostate.
|
Int J Cancer
|
2001
|
0.75
|
|
60
|
Identification of a homozygous deletion at 8p12-21 in a human prostate cancer xenograft.
|
Genes Chromosomes Cancer
|
1999
|
0.75
|
|
61
|
Human prostate tumor xenografts as representative models for clinical prostate cancer.
|
Urol Oncol
|
2011
|
0.75
|
|
62
|
Unresponsiveness of the reproductive organs of the male mouse to treatment with a potent luteinizing hormone-releasing hormone agonist (ICI-118,630).
|
Urol Res
|
1984
|
0.75
|